Skip to content

GENERAL MOTORS INVESTMENT MANAGEMENT CORP

Follow

13F filer, CIK 883422, NEW YORK, NY

GENERAL MOTORS INVESTMENT MANAGEMENT CORP reported $2,546,000 across 1 holding for the quarter ended 2015-12-31, in a 13F-HR filed 2016-02-09.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001140361-16-050944

Period
2015-12-31
Reported value
$2.55M
Holdings
1
Top 10 weight
100%
New
1
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MAXPOINT INTERACTIVE INCnew+1,489,048$2.55M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CLOVIS ONCOLOGY INCexited-24,952-$2.29M
VITAE PHARMACEUTICALS INCexited-26,023-$287K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2015

Share positions as resolved from 13F-HR 0001140361-16-050944, largest first. % of portfolio is the value over $2,546,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MAXPOINT INTERACTIVE INCMAXPOINT INTERACTIVE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: not reported; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 1,489,048 shares 1,489,048$2.55M100%new

Sold out in Q4 2015

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CLOVIS ONCOLOGY INCCLOVIS ONCOLOGY INC24,952$2.29Mshares
VITAE PHARMACEUTICALS INCVITAE PHARMACEUTICALS INC26,023$287Kshares
ARM HLDGS ORD GBP0.5ARM HLDGS ORD GBP0.50$0shares

How Q4 2015 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001140361-16-050944 base2016-02-09acceptance time not in the bulk data set